These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10811303)

  • 21. Regulation of the protein-loading capacity of hydroxyapatite by mercaptosuccinic acid modification.
    Ishihara S; Matsumoto T; Onoki T; Uddin MH; Sohmura T; Nakahira A
    Acta Biomater; 2010 Mar; 6(3):830-5. PubMed ID: 19836474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanical properties and osteoconductivity of porous bioactive titanium.
    Takemoto M; Fujibayashi S; Neo M; Suzuki J; Kokubo T; Nakamura T
    Biomaterials; 2005 Oct; 26(30):6014-23. PubMed ID: 15885769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of porous ceramics with well-controlled porosities and pore sizes from apatite fibers and their evaluations.
    Kawata M; Uchida H; Itatani K; Okada I; Koda S; Aizawa M
    J Mater Sci Mater Med; 2004 Jul; 15(7):817-23. PubMed ID: 15387418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabrication of hydroxyapatite ceramics with controlled pore characteristics by slip casting.
    Yao X; Tan S; Jiang D
    J Mater Sci Mater Med; 2005 Feb; 16(2):161-5. PubMed ID: 15744605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyapatite/poly(epsilon-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery.
    Kim HW; Knowles JC; Kim HE
    Biomaterials; 2004; 25(7-8):1279-87. PubMed ID: 14643602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Freeze-cast hydroxyapatite scaffolds for bone tissue engineering applications.
    Fu Q; Rahaman MN; Dogan F; Bal BS
    Biomed Mater; 2008 Jun; 3(2):025005. PubMed ID: 18458369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 1-year study of osteoinduction in hydroxyapatite-derived biomaterials in an adult sheep model: part I.
    Gosain AK; Song L; Riordan P; Amarante MT; Nagy PG; Wilson CR; Toth JM; Ricci JL
    Plast Reconstr Surg; 2002 Feb; 109(2):619-30. PubMed ID: 11818845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoconductivity and osteoinductivity of porous hydroxyapatite coatings deposited by liquid precursor plasma spraying: in vivo biological response study.
    Huang Y; He J; Gan L; Liu X; Wu Y; Wu F; Gu ZW
    Biomed Mater; 2014 Nov; 9(6):065007. PubMed ID: 25384201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase development and sintering behaviour of biphasic HA-TCP calcium phosphate materials prepared from hydroxyapatite and bioactive glass.
    Behnamghader A; Bagheri N; Raissi B; Moztarzadeh F
    J Mater Sci Mater Med; 2008 Jan; 19(1):197-201. PubMed ID: 17597356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porous hydroxyapatite tablets as carriers for low-dosed drugs.
    Cosijns A; Vervaet C; Luyten J; Mullens S; Siepmann F; Van Hoorebeke L; Masschaele B; Cnudde V; Remon JP
    Eur J Pharm Biopharm; 2007 Sep; 67(2):498-506. PubMed ID: 17407810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectroscopic characterization of porous nanohydroxyapatite synthesized by a novel amino acid soft solution freezing method.
    Gopi D; Indira J; Prakash VC; Kavitha L
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Sep; 74(1):282-4. PubMed ID: 19525142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gel.
    Hoang Thi TH; Chai F; Leprêtre S; Blanchemain N; Martel B; Siepmann F; Hildebrand HF; Siepmann J; Flament MP
    Int J Pharm; 2010 Nov; 400(1-2):74-85. PubMed ID: 20816734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A synthetic bone implant macroscopically identical to cancellous bone.
    Tancred DC; McCormack BA; Carr AJ
    Biomaterials; 1998 Dec; 19(24):2303-11. PubMed ID: 9884044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyapatite particles as a controlled release carrier of protein.
    Matsumoto T; Okazaki M; Inoue M; Yamaguchi S; Kusunose T; Toyonaga T; Hamada Y; Takahashi J
    Biomaterials; 2004 Aug; 25(17):3807-12. PubMed ID: 15020156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on hydroxyapatite porous scaffold bonded by phosphates and its biocompatibility].
    Dong Y; Zhang Q; Liu B; Guo Z; Lin P; Pu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Oct; 22(5):985-9. PubMed ID: 16294736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and evaluation of porous poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) hydroxyapatite composite scaffolds.
    Jing Xi ; Ling Zhang ; Zhenhu An Zheng ; Guoqiang Chen ; Yandao Gong ; Nanming Zhao ; Xiufang Zhang
    J Biomater Appl; 2008 Jan; 22(4):293-307. PubMed ID: 18089673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fabrication of low temperature macroporous hydroxyapatite scaffolds by foaming and hydrolysis of an alpha-TCP paste.
    Almirall A; Larrecq G; Delgado JA; Martínez S; Planell JA; Ginebra MP
    Biomaterials; 2004 Aug; 25(17):3671-80. PubMed ID: 15020142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigations on the synthesis and crystallization of hydroxyapatite at low temperature.
    Kalkura SN; Anee TK; Ashok M; Betzel C
    Biomed Mater Eng; 2004; 14(4):581-92. PubMed ID: 15472405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphasic mode of antibacterial action of aminoglycoside antibiotics-loaded elastic hydroxyapatite-glucan composite.
    Belcarz A; Zima A; Ginalska G
    Int J Pharm; 2013 Sep; 454(1):285-95. PubMed ID: 23850627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method to fabricate porous spherical hydroxyapatite granules intended for time-controlled drug release.
    Komlev VS; Barinov SM; Koplik EV
    Biomaterials; 2002 Aug; 23(16):3449-54. PubMed ID: 12099288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.